High Tech Pharmaceuticals Co., Ltd. logo

High Tech Pharmaceuticals Co., Ltd. (106190)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
11,520. 00
-360
-3.0303%
168.1B Market Cap
- P/E Ratio
266.67% Div Yield
9,737 Volume
- Eps
11,880
Previous Close
Add Transaction
Day Range
11,460 11,950
Year Range
9,540 25,000
Want to track 106190 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

High Tech Pharmaceuticals Co., Ltd. (106190) Statistics

Valuation metrics

Market Cap 168.1B
Enterprise value 149.35B
Trailing P/E (ttm) 11.96
Forward P/E -
PEG ratio 0.2
Price/Sales (ttm) 2.4
Price/Book (mrq) 1.29
Enterprise Value/Revenue 2.13
Enterprise Value/EBITDA 8.17

Overview

Shares outstanding 10.63M
Float 5.81M
Shares short -
% Held by insiders 0.45%
% Held by institutions 0%
Average volume (10 days) 63.64K
Average volume (90 days) 68.17K

Price summary

52-Week low 9,540
52-Week high 25,000
Beta 0.06
50-Day moving average 18,597.6
200-Day moving average 14,196.05

Dividends and splits

Forward annual dividend rate 266.67
Forward annual dividend yield 0.0169%
Trailing annual dividend rate 66.67
Trailing annual dividend yield 0.0042%
5-Year annual dividend yield 0.63%
Payout ratio 0.18
Dividend Date 3 Jan 2025
Ex-Dividend Date 27 Dec 2024
Last split factor 1:1
Last split Date 27 Dec 2023

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.16%
Operating margin 0.23%

Operational effectiveness

Return on assets 0.06%
Return on equity 0.09%

Income Statement

Revenue (ttm) 70.18B
Revenue per share (ttm) 6,600.75
Quarterly revenue growth (yoy) -0.28%
Gross profit (ttm) 16.94B
EBITDA 17.76B
Net income to common (ttm) 11.48B
Diluted EPS (ttm) 1,289
Quarterly earnings growth (yoy) -0.14%

Balance Sheet

Total cash (mrq) 14.43B
Total cash per share (mrq) 1,357.12
Total debt (mrq) 33.61M
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 5.67%
Book value per share (mrq) 11,943.64

Cash Flow

Cash flow statement 17.03B
Levered free cash flow (LFCF) 13.25B